Synonyms:
Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 6RH6DL8R4L

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Angiopoietin-2 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 1 D009369 ClinicalTrials
Melanoma 1 D008545 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109298
FDA SRS 6RH6DL8R4L